Science Explorer Back to mapMap
Discussion
Company · Sesto Fiorentino · Italy

Eli Lilly (Italy)

lilly.itROR OpenAlex
Research works
116
▼ 12% vs 2018-21
Citations
2.8k
24.0 per fractional work
Top-10% rate
9.6%
all institutions 10.0%
Open access
45%
world 40%
International
47%
world 18%
Eli Lilly (Italy)

Not ranked overall: Eli Lilly (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Eli Lilly (Italy) work in?

In all years, 72% of research at Eli Lilly (Italy) is in Health Sciences, 19% in Life Sciences. Its largest fields are Medicine (70%), Biochemistry, Genetics and Molecular Biology (9%), Neuroscience (4%). It does 2.9× the world's share of Health Sciences.

Health Sciences: 83 fractional works · 71.6% of its workMedicine: 81 fractional works · 70.2% of its workEndocrinology, Diabetes and Metabolism: 17 fractional works · 14.8% of its workPsychiatry and Mental health: 14 fractional works · 12.3% of its workOncology: 7 fractional works · 6.0% of its workPulmonary and Respiratory Medicine: 6 fractional works · 4.9% of its workRheumatology: 5 fractional works · 4.5% of its workPharmacology: 4 fractional works · 3.2% of its workPhysiology: 3 fractional works · 2.7% of its workSurgery: 3 fractional works · 2.4% of its workPediatrics, Perinatology and Child Health: 3 fractional works · 2.4% of its workEpidemiology: 3 fractional works · 2.2% of its workDermatology: 2 fractional works · 1.3% of its workGenetics: 1 fractional works · 1.3% of its workOrthopedics and Sports Medicine: 1 fractional works · 1.1% of its workHematology: 1 fractional works · 1.1% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.1% of its workUrology: 1 fractional works · 1.0% of its workNeurology: 1 fractional works · 0.9% of its workReproductive Medicine: 1 fractional works · 0.9% of its workPathology and Forensic Medicine: 1 fractional works · 0.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.8% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.7% of its workGeriatrics and Gerontology: 1 fractional works · 0.6% of its workFamily Practice: 1 fractional works · 0.6% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.5% of its workGastroenterology: 1 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.7% of its workHealth Professions: 1 fractional works · 0.8% of its workGeneral Health Professions: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workLife Sciences: 22 fractional works · 18.9% of its workBiochemistry, Genetics and Molecular Biology: 11 fractional works · 9.3% of its workMolecular Biology: 4 fractional works · 3.8% of its workGenetics: 4 fractional works · 3.3% of its workCancer Research: 1 fractional works · 1.2% of its workEndocrinology: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workNeuroscience: 5 fractional works · 4.0% of its workCellular and Molecular Neuroscience: 2 fractional works · 1.7% of its workCognitive Neuroscience: 1 fractional works · 0.8% of its workEndocrine and Autonomic Systems: 1 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 3 fractional works · 2.8% of its workImmunology: 3 fractional works · 2.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 2 fractional works · 2.1% of its workAgronomy and Crop Science: 1 fractional works · 1.0% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.3% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.3% of its workToxicology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 6 fractional works · 5.1% of its workPsychology: 3 fractional works · 2.4% of its workClinical Psychology: 2 fractional works · 1.4% of its workExperimental and Cognitive Psychology: 1 fractional works · 0.7% of its workSocial Psychology: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 2 fractional works · 1.7% of its workEconomics and Econometrics: 2 fractional works · 1.7% of its workSocial Sciences: 1 fractional works · 0.6% of its workEducation: 0 fractional works · 0.2% of its workSociology and Political Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.3% of its workLiterature and Literary Theory: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 5 fractional works · 4.4% of its workComputer Science: 1 fractional works · 1.2% of its workArtificial Intelligence: 1 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.4% of its workChemistry: 1 fractional works · 1.1% of its workAnalytical Chemistry: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 1 fractional works · 0.9% of its workCivil and Structural Engineering: 0 fractional works · 0.3% of its workBiomedical Engineering: 0 fractional works · 0.2% of its workElectrical and Electronic Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 0.7% of its workGlobal and Planetary Change: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.5% of its workPhysics and Astronomy: 1 fractional works · 0.5% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.1% of its workALL ITS WORKEli Lilly (Italy)116fractional works, all years
Life Sciences19%Physical Sciences4%Health Sciences72%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine8170.2%
    2. Health Professions10.8%
    3. Nursing00.3%
    4. Veterinary00.3%
    1. Biochemistry, Genetics and Molecular Biology119.3%
    2. Neuroscience54.0%
    3. Immunology and Microbiology32.8%
    4. Agricultural and Biological Sciences22.1%
    5. Pharmacology, Toxicology and Pharmaceutics10.7%
    1. Psychology32.4%
    2. Economics, Econometrics and Finance21.7%
    3. Social Sciences10.6%
    4. Arts and Humanities00.3%
    5. Decision Sciences00.1%
    1. Computer Science11.2%
    2. Chemistry11.1%
    3. Engineering10.9%
    4. Environmental Science10.7%
    5. Physics and Astronomy10.5%
    6. Earth and Planetary Sciences00.1%
    7. Materials Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.58× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.95× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 8.21× its world share, 2 worksImmunology and Micro…Neuroscience: 0.53× its world share, 0 worksNeuroscienceComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.12× its world share, 0 worksEngineeringEnvironmental Science: 0.27× its world share, 0 worksEnvironmental SciencePhysics and Astronomy: 0.78× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.03× its world share, 0 worksHealth ProfessionsMedicine: 3.59× its world share, 13 worksMedicineVeterinary: 4.28× its world share, 0 worksVeterinaryDecision Sciences: 0.11× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.08× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.2×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Immunology and Microbiology8.21×2 works
  2. Veterinary4.28×0 works
  3. Medicine3.59×13 works
  4. Biochemistry, Genetics and Molecular Biology1.95×2 works
  5. Economics, Econometrics and Finance1.08×0 works
  6. Physics and Astronomy0.78×0 works
  7. Agricultural and Biological Sciences0.58×0 works
  8. Neuroscience0.53×0 works
  9. Environmental Science0.27×0 works
  10. Engineering0.12×0 works
  11. Decision Sciences0.11×0 works
  12. Computer Science0.07×0 works
  13. Health Professions0.03×0 works
  14. Social Sciences0.01×0 works

Who are the top researchers at Eli Lilly (Italy)?

Ranked on the quality score, Grazia Dell’Agnello, Marco Orsini Federici and Raffaella Gentilella lead among researchers whose main affiliation is Eli Lilly (Italy).

  1. 1 Grazia Dell’Agnello Italy · #1,159,531 worldwide 2.7k citations · 74 works
  2. 2 Marco Orsini Federici Italy · #2,219,853 worldwide 2.4k citations · 64 works
  3. 3 Raffaella Gentilella Italy · #2,572,719 worldwide 1.2k citations · 45 works
  4. 4 Domenico Valle Italy · #2,581,131 worldwide 1.5k citations · 28 works
  5. 5 Andrea Rossi Italy · #3,009,006 worldwide 533 citations · 29 works
  6. 6 Erica Filippi Italy · #3,056,137 worldwide 144 citations · 15 works
  7. 7 Ester Romoli Italy · #3,321,983 worldwide 232 citations · 17 works
  8. 8 Serena Losi Italy · #3,643,369 worldwide 291 citations · 34 works
  9. 9 Pietro Donda Italy · #3,832,763 worldwide 245 citations · 16 works
  10. 10 Veronica Rogai Italy · #4,014,013 worldwide 398 citations · 24 works
All ranked researchers at Eli Lilly (Italy)

What are the most cited papers from Eli Lilly (Italy)?

The most cited paper from Eli Lilly (Italy) is "Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial" (Hansjochen Wilke, Kei Muro, Eric Van Cutsem et al., 2014), with 2,505 citations. Next come "Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges" (586) and "A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis" (337).

Most cited papers
#PaperReleasedCitations
1 Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hansjochen Wilke, Kei Muro, Eric Van Cutsem et al. · The Lancet Oncology 17 Sep 2014 2,505
2 Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges Bruno Dubois, Alessandro Padovani, Philip Scheltens et al. · Journal of Alzheimer s Disease Open access 17 Oct 2015 586
3 A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis Joint IOF-ECTS GIO Guidelines Working Group et al. · Osteoporosis International 20 Mar 2012 337
4 Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial Luigi Dogliotti, Giacomo Cartenì, Salvatore Siena et al. · European Urology 2 Jan 2007 332
5 A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum Vito Lorusso, C. F. Pollera, Mauro Antimi et al. · European Journal of Cancer Jul 1998 289
All 61 most cited papers, with filters and sorting

Which keywords describe research at Eli Lilly (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Depression, Breast Cancer, Metabolic Syndrome, Clinical Guidelines, Biomarkers and Cardiovascular Disease.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control9▲ 57×4 topics
  2. Insulin Therapy9▲ 69×3 topics
  3. Depression8▲ 8.8×12 topics
  4. Breast Cancer8▲ 23×8 topics
  5. Inflammation7▲ 2.7×19 topics
  6. Metabolic Syndrome7▲ 7.4×12 topics
  7. Cardiovascular Disease7▲ 5.4×7 topics
  8. Clinical Guidelines7▲ 19×5 topics
  9. Biomarkers6▲ 8.3×7 topics
  10. Chemotherapy6▲ 7.2×17 topics
  11. Diabetes6▲ 9.8×8 topics
  12. Type 2 Diabetes6▲ 26×5 topics
  13. Cancer5▲ 3.2×10 topics
  14. Clinical Trials5▲ 7.3×10 topics
  15. Neuroimaging5▲ 16×5 topics
  16. Cardiovascular Risk5▲ 12×6 topics
  17. Alzheimer's Disease5▲ 15×6 topics
  18. Neurological Disorders4▲ 5.6×11 topics
  19. Estrogen4▲ 49×2 topics
  20. Heart Failure4▲ 8.2×4 topics
  21. Cardiovascular Outcomes4▲ 83×1 topic
  22. Glucose Control4▲ 83×1 topic
  23. Growth Hormone4▲ 41×2 topics
  24. Aging4▲ 6.3×3 topics
  25. Caregiver Burden4▲ 39×2 topics
  26. Dementia4▲ 45×2 topics
  27. Cognitive Decline4▲ 29×1 topic
  28. Complications4▲ 6.1×4 topics
  29. Mild Cognitive Impairment4▲ 50×1 topic
  30. Cognitive Function4▲ 15×5 topics
  31. Prognostic Factors3▲ 6.5×6 topics
  32. Neuroendocrine Control3▲ 43×2 topics
  33. Targeted Therapy3▲ 13×3 topics
  34. Type 1 Diabetes3▲ 30×2 topics
  35. Continuous Glucose Monitoring3▲ 58×1 topic
  36. Hypoglycemia3▲ 58×1 topic
  37. IGF-13▲ 57×1 topic
  38. Insulin-like Growth Factors3▲ 57×1 topic
  39. Synaptic Plasticity3▲ 8.5×3 topics
  40. Treatment Guidelines3▲ 12×2 topics

Which research topics does Eli Lilly (Italy) publish most on?

By volume in 2022-now: Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies and Advanced Breast Cancer Therapies.

Psoriasis: Treatment and Pathogenesis: 2 fractional worksSpondyloarthritis Studies and Treatments: 1 fractional worksRheumatoid Arthritis Res…1Rheumatoid Arthritis Research and Therapies: 1 fractional worksAdvanced Breast Cancer T…1Advanced Breast Cancer Therapies: 1 fractional worksBreast Cancer Treatment Studies: 1 fractional worksChronic Lymphocytic Leukemia Research: 1 fractional worksCAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksCancer-related Molecular Pathways: 0 fractional worksMedical Imaging Techniques and Applications: 0 fractional worksPharmaceutical studies and practices: 0 fractional works
ImmunologyRheumatologyPulmonary and Respiratory MedicineCancer Research4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  2. 2 Spondyloarthritis Studies and Treatments Rheumatology 1 works
  3. 3 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  5. 5 Breast Cancer Treatment Studies Cancer Research 1 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 1 works
  7. 7 CAR-T cell therapy research Oncology 1 works
  8. 8 Cancer-related Molecular Pathways Oncology 0 works
  9. 9 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.1%not open54.9%

World: 40% of research is openly available.

with international co-authors46.6%domestic only53.4%

World: 18% is written across borders.

How has Eli Lilly (Italy)'s research output changed?

Output in 2022-2025 was 12% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eli Lilly (Italy) as a percentage of every work published that year, 0.000041% in 2024.

still counting0.00020%0.00040%Eli Lilly (Italy)0.000025% in 202519801990200020102020

Fractional works of Eli Lilly (Italy) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Sesto Fiorentino

All research institutions in Sesto Fiorentino

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eli Lilly (Italy). Posts are plain text and can be reported.